Differentiating renal pelvic cancer from renal cell carcinoma with 18-fluorodeoxyglucose positron emission tomography-computed tomography.


Dursun M., Ozbek E., Otunctemur A., Besiroglu H.

Journal of cancer research and therapeutics, vol.17, no.4, pp.901-905, 2021 (SCI-Expanded, Scopus)

  • Publication Type: Article / Article
  • Volume: 17 Issue: 4
  • Publication Date: 2021
  • Doi Number: 10.4103/jcrt.jcrt_217_16
  • Journal Name: Journal of cancer research and therapeutics
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.901-905
  • Keywords: 18-fluorodeoxyglucose positron emission tomography, renal cell carcinoma, maximum standardized uptake value, UPPER URINARY-TRACT, UROTHELIAL CARCINOMA, DIAGNOSIS, NEOPLASMS, URETER, RISK, PET, CT
  • Istanbul University-Cerrahpasa Affiliated: Yes

Abstract

Background: The differential diagnosis of pelvis renalis cancer (PRC) from renal cell cancer (RCC) is difficult. Because of that, in this study, we compared the standardized uptake value (SUV) with positron emission tomography-computed tomography (PET-CT) of the RCC and PRC.